Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of β-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1α and heparin
- 1 November 1983
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 32 (4) , 393-408
- https://doi.org/10.1016/0049-3848(83)90092-0
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hemodialysis Using Prostacyclin Instead of Heparin as the Sole Antithrombotic AgentNew England Journal of Medicine, 1981
- PLATELET PROTECTION AND HEPARIN SPARING WITH PROSTACYCLIN DURING REGULAR DIALYSIS THERAPYThe Lancet, 1980
- PROSTACYCLIN TO PREVENT PLATELET ACTIVATION DURING CHARCOAL HÆMOPERFUSION IN FULMINANT HEPATIC FAILUREThe Lancet, 1980
- PROSTACYCLIN: A SOLUTION TO SOME PROBLEMS OF EXTRACORPOREAL CIRCULATIONThe Lancet, 1979
- PROSTACYCLIN CAN REPLACE HEPARIN IN HÆMODIALYSIS IN DOGSThe Lancet, 1978
- Biocompatibility of coated and uncoated charcoal during haemoperfusion in healthy dogsEuropean Journal of Clinical Investigation, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Alterations of Hemostasis Associated With Cardiopulmonary Bypass: Pathophysiology, Prevention, Diagnosis, and ManagementSeminars in Thrombosis and Hemostasis, 1976
- The hemostatic mechanism after open-heart surgeryThe Journal of Thoracic and Cardiovascular Surgery, 1975
- The hemostatic mechanism after open-heart surgeryThe Journal of Thoracic and Cardiovascular Surgery, 1975